These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1003 related items for PubMed ID: 23890879

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.
    Li J, Liu J, Liu M, Zhang S, Hao Z, Zhang J, Zhang C.
    Cochrane Database Syst Rev; 2015 Sep 08; 2015(9):CD009938. PubMed ID: 26346232
    [Abstract] [Full Text] [Related]

  • 5. Percutaneous Closure of Patent Foramen Ovale in Patients with Cryptogenic Stroke - An Updated Comprehensive Meta-Analysis.
    Sitwala P, Khalid MF, Khattak F, Bagai J, Bhogal S, Ladia V, Mukherjee D, Daggubati R, Paul TK.
    Cardiovasc Revasc Med; 2019 Aug 08; 20(8):687-694. PubMed ID: 30282597
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.
    Khan AR, Bin Abdulhak AA, Sheikh MA, Khan S, Erwin PJ, Tleyjeh I, Khuder S, Eltahawy EA.
    JACC Cardiovasc Interv; 2013 Dec 08; 6(12):1316-23. PubMed ID: 24139929
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events.
    Pineda AM, Nascimento FO, Yang SC, Kirtane AJ, Sommer RJ, Beohar N.
    Catheter Cardiovasc Interv; 2013 Nov 15; 82(6):968-75. PubMed ID: 23832613
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Amplatzer PFO occluder device may prevent recurrent stroke in patients with patent foramen ovale and cryptogenic stroke: a meta-analysis of randomised trials.
    Pandit A, Aryal MR, Pandit AA, Jalota L, Kantharajpur S, Hakim FA, Lee HR.
    Heart Lung Circ; 2014 Apr 15; 23(4):303-8. PubMed ID: 24495944
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials.
    Pickett CA, Villines TC, Ferguson MA, Hulten EA.
    Tex Heart Inst J; 2014 Aug 15; 41(4):357-67. PubMed ID: 25120387
    [Abstract] [Full Text] [Related]

  • 14. Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism.
    Agarwal S, Bajaj NS, Kumbhani DJ, Tuzcu EM, Kapadia SR.
    JACC Cardiovasc Interv; 2012 Jul 15; 5(7):777-89. PubMed ID: 22814784
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Stroke: Meta-Analysis of Randomised Trials.
    Wang TKM, Wang MTM, Ruygrok P.
    Heart Lung Circ; 2019 Apr 15; 28(4):623-631. PubMed ID: 29602754
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Patent foramen ovale closure versus medical therapy for cryptogenic stroke: An updated meta-analysis.
    Xu HB, Zhang H, Qin Y, Xue F, Xiong G, Yang L, Bai H, Wu J.
    J Neurol Sci; 2018 Jul 15; 390():139-149. PubMed ID: 29801875
    [Abstract] [Full Text] [Related]

  • 19. Patent Foramen Ovale Closure Versus Medical Therapy in Cryptogenic Strokes and Transient Ischemic Attacks: A Meta-Analysis of Randomized Trials.
    Vidale S, Russo F, Campana C, Agostoni E.
    Angiology; 2019 Apr 15; 70(4):325-331. PubMed ID: 30270651
    [Abstract] [Full Text] [Related]

  • 20. Patent foramen ovale closure versus medical therapy after cryptogenic stroke: An updated meta-analysis of all randomized clinical trials.
    Kheiri B, Abdalla A, Osman M, Ahmed S, Hassan M, Bachuwa G.
    Cardiol J; 2019 Apr 15; 26(1):47-55. PubMed ID: 29512097
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 51.